Mantle cell lymphoma surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3]. | The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3]. | ||
==Indications== | ==Indications== | ||
*The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either: | *The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either: | ||
**[Indication 1] | **[Indication 1] | ||
Line 36: | Line 16: | ||
**[Indication 3] | **[Indication 3] | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} |
Revision as of 01:37, 11 December 2018
Mantle cell lymphoma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Mantle cell lymphoma surgery On the Web |
American Roentgen Ray Society Images of Mantle cell lymphoma surgery |
Risk calculators and risk factors for Mantle cell lymphoma surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ali Akram, M.B.B.S.[2] Sowminya Arikapudi, M.B,B.S. [3]
Overview
The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either [indication 1], [indication 2], and/or [indication 3].
Indications
- The mainstay of treatment for [disease name] is medical therapy. Surgery is usually reserved for patients with either:
- [Indication 1]
- [Indication 2]
- [Indication 3]